RxDoctor Payments Data

Steven Yarows, MD

Internal Medicine · Chelsea, MINPI 1275532087

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,064 of the $4,206 with a category attached, or 96.6%. 5 manufacturers reported payments, led by Hill-rom Services, Inc at 32.3% of the total. Among internal medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,206in general payments, 2019–2025

Across 8 payments — averaging $525.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hill-rom Services, Inc$1K
  • Baxter Healthcare$1K
  • AstraZeneca$1K
  • Welch Allyn$375
  • Gilead$27
$16,594in research payments, 2019–2025

Across 1 payment — averaging $16,594 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi-aventis U.S. LLC$17K

What the payments were for

  • Consulting fees$4,06497%
  • Food & beverage$1423%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Hill-rom Services, Inc1$1,360
Baxter Healthcare1$1,225
AstraZeneca3$1,219
Welch Allyn2$375
Gilead1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,206 in reported general payments places this provider in the 90th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan →

Medicare billing

Part B allowed, 2024
$108,097
Medicare patients
387
Services billed
1,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban190$218,621
XareltoRivaroxaban178$216,710
TrulicityDulaglutide39$64,544
JardianceEmpagliflozin59$63,484
RybelsusSemaglutide21$40,825
OzempicSemaglutide18$29,832
Fluticasone-SalmeterolFluticasone Propion/Salmeterol110$22,894
Irbesartan495$16,604
Atorvastatin Calcium790$15,010
WegovySemaglutide11$14,445
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$11,557
Rosuvastatin Calcium440$10,916
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide134$9,163
Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide170$7,771
Albuterol Sulfate HfaAlbuterol Sulfate188$7,519

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chelsea

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →